Search EN menu en EIB GROUP CLIENT PORTAL
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

    Signature(s)

    Amount
    € 100,000,000
    Countries
    Sector(s)
    Denmark : € 100,000,000
    Industry : € 100,000,000
    Signature date(s)
    7/01/2019 : € 100,000,000

    Summary sheet

    Release date
    18 January 2019
    Status
    Reference
    Signed | 07/01/2019
    20180291
    Project name
    Promoter - financial intermediary
    NOVOZYMES BIOTECHNOLOGY INNOVATION II
    NOVOZYMES A/S
    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    EUR 100 million
    EUR 272 million
    Location
    Sector(s)
    Description
    Objectives

    The project consists of the financing of Novozymes' research, development and innovation (RDI) activities for the development of biological solutions, industrial enzymes and microorganisms.

    The RDI activities will focus on the development of products and solutions that enhance product quality and process/energy efficiency in industries such as detergents, food and beverages, bioenergy, agriculture and feed and technical industries.

    Environmental aspects
    Procurement

    The project concerns investments in research and development that are expected to be carried out in existing facilities, already authorised, and which would therefore not require an environmental impact assessment (EIA) 2014/52/EU amending the EIA Directive 2011/92/EC. Full environmental details will be verified during the appraisal.

    The promoter is a private company not operating in the utilities sector, and is thus not covered by EU directives on procurement.

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
    They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Documents

    Environmental and Social Data Sheet (ESDS) - NOVOZYMES BIOTECHNOLOGY INNOVATION II
    Publication Date
    13 Mar 2019
    Document language
    Main Topic
    Lending
    Document Number
    83885135
    Document Focus
    Environmental Information
    Project Number
    20180291
    Sector(s)
    Regions
    Countries
    Publicly available
    Download now
    Environmental and Social Completion Sheet (ESCS) - NOVOZYMES BIOTECHNOLOGY INNOVATION II
    Publication Date
    25 Dec 2021
    Document language
    Main Topic
    Lending
    Document Number
    151867846
    Document Focus
    Environmental Information
    Project Number
    20180291
    Sector(s)
    Regions
    Countries
    Publicly available
    Download now

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Investigations Division. All reports will be treated as strictly confidential and handled in line with EIB investigation procedures and the EIB Group Anti-Fraud Policy.

    Related publications